Pharma Co. Sued For $12M For Underpaying Board Chair
By Katryna Perera · April 29, 2022, 7:34 PM EDT
Altum Pharmaceuticals and its cannabis-focused parent company were hit with a $12 million suit Thursday, accusing the companies and several executives of self-dealing and stock dilution and underpaying the executive chairman...
To view the full article, register now.